|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Jan―10 |
Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study |
Rajib Hossain, Shafi Mahmud, Abul Bashar Ripon Khalipha, Abu Saim Mohammad Saikat, Dipta Dey, Rasel Ahmed Khan, et al. (+11) Abdur Rauf, Abdur Abdul Wadood, Humaria Rafique, Sami Bawazeer, Anees Ahmed Khalil, Zainab M. Almarhoon, Yahia N. Mabkhot, Khalid J. Alzahrani, Muhammad Torequl Islam, Khalaf F. Alsharif, Haroon Khan |
2 |
[GO] |
2022―Nov―25 |
DFT, molecular docking and ADME prediction of tenofovir drug as a promising therapeutic inhibitor of SARS-CoV-2 Mpro |
Siyamak Shahab, Masoome Sheikhi, Maksim Khancheuski, Hooriye Yahyaei, Hora Alhosseini Almodarresiyeh, Sadegh Kaviani |
3 |
[GO] |
2021―Nov―02 |
Quantum processing of cytidine derivatives and evaluating their in silico interactions with the COVID-19 main protease |
Kun Harismah, Narjes Hajali, Mahmoud Mirzaei, Elham Salarrezaei |
4 |
[GO] |
2021―Aug―03 |
Comparative study of molecular docking, structural, electronic, vibrational and hydrogen bonding interactions on 4-hydroxy benzo hydrazide (4HBH) and its newly designed derivative [(E)-N′-((1H-Pyrrol-2-YL)methylene) -4-hydroxy benzo hydrazide and its isomers (I, II and III)] (potential inhibitors) for COVID-19 protease |
Anoop Kumar Pandey, Vijay Singh, Apoorva Dwivedi |
|